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Abstract
Objective—To provide researchers an extensive characterization of the SPECTRUM variable 
nicotine research cigarettes.
Methods—Data on cigarette physical properties, nicotine content, harmful and potentially 
harmful constituents in the tobacco filler was compiled.
Results—Data on physical properties, concentrations of menthol, nicotine and minor alkaloids, 
tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, ammonia, and toxic metals in 
the filler tobacco for all available varieties of Spectrum research cigarettes are provided. The 
similarity in the chemistry and physical properties of SPECTRUM cigarettes to commercial 
cigarettes renders them acceptable for use in behavioral studies. Baseline information on harmful 
and potentially harmful constituents in research tobacco products, particularly constituent levels 
such as minor alkaloids that fall outside typical ranges reported for commercial, provide 
researchers with the opportunity to monitor smoking behavior and to identify biomarkers that will 
inform efforts to understand the role of nicotine in creating and sustaining addiction.
Conclusions—Well characterized research cigarettes suitable for human consumption are an 
important tool in clinical studies for investigating the physiological impacts of cigarettes 
delivering various levels of nicotine, the impact of reduced nicotine cigarettes on nicotine 
addiction, and the relationship between nicotine dose and smoking behavior.
Keywords
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INTRODUCTION
The 22nd Century Group, Inc. uses a combination of techniques including genetic 
engineering and plant breeding to provide cigarette tobacco filler with reduced nicotine 
content. The 22nd Century Group manufactured variable nicotine cigarettes under 
subcontract with the Research Triangle Institute (RTI).1 The modified nicotine cigarettes 
include a minimal (placebo) nicotine delivery level, menthol and non-mentholated varieties, 
and eight target nicotine delivery levels. The products also differ in tar deliveries, 
ventilation, and levels of other constituents. A total of 23 cigarette configurations are made 
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available to researchers through NIDA’s Drug Supply Program under the name, 
“SPECTRUM.”1,2
Unlike other research tobacco products, SPECTRUM cigarettes provide researchers with a 
variable nicotine cigarette that is “suitable” for smoking by human test subjects.3 Some 
research incorporating SPECTRUM cigarettes has already been published and more is 
expected due to multiple funding opportunities intended to facilitate research that will help 
inform the U.S. Food and Drug Administration in priority research areas including 
dependence thresholds and the impact of nicotine reduction on tobacco product use 
behavior.3–5
Nicotine addiction and its relation to smoking behavior is complex. The manner in which a 
smoker utilizes the product and levels of chemical constituents in tobacco and smoke 
determine the exposure to smoke constituents.6 In addition to general considerations of 
toxicity, some tobacco smoke constituents like acetaldehyde7 are also thought to be a factor 
in addiction. Therefore additional data on the characterization of the SPECTRUM cigarettes 
will inform researchers using variable nicotine cigarettes in behavioral, addiction, exposure 
biomonitoring, cessation, and other tobacco-related studies.
We report here an extensive characterization of physical properties and constituent levels for 
SPECTRUM variable nicotine research cigarettes. This characterization includes the 
physical properties of the cigarettes (length, pressure drop, filter ventilation, filter 
circumference, rod circumference, filter length, tobacco length, over wrap length, air 
permeability, and tobacco weight and cigarette weight) as well as menthol, nicotine, minor 
alkaloids, and several major classes of harmful and potentially harmful organic and 
inorganic chemical constituents in the tobacco.
METHODS
Twenty-three varieties of SPECTRUM research cigarettes were obtained from NIDA 
(Bethesda, MD, USA) in 2014 and stored in original packaging after receipt.
Results are reported on an “as received” basis unless otherwise noted.
Physical properties
After conditioning the cigarettes according to ISO 3402 (1999) specifications, physical 
property determinations were performed using a C2 instrument (Cerulean, Milton Keynes, 
UK). Five replicate measurements were made on each cigarette variety to determine 
cigarette length, pressure drop, filter ventilation, filter circumference, rod circumference, 
filter length, tobacco length, and over wrap length. Air permeability was determined using a 
PPM1000M instrument (Cerulean, Milton Keynes, UK).
Tobacco filler and cigarette weights were determined manually with calibrated and certified 
balances.
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Quantitative analytical measurements
All quantitative methods were performed in a strict QA/QC environment. Each analytical 
method below has been full validated and has sufficient dynamic range for all samples. The 
limits of detections for each method was obtained using Taylor’s method.8 All reported data 
fall between the lowest and highest calibration curve point. Any measured values lower than 
the lowest calibration point are reported as non-detects. All run QC were checked using a 
modified Westgard protocol.9 Any QC failures were excluded and samples repeated if 
needed. All data were reviewed by a quality control officer and quality manager prior to 
release.
Menthol
Previously unopened packages of cigarettes were used for menthol analysis to minimize 
substantial evaporative losses. Sample preparation procedures were described previously.10 
Tobacco menthol levels were determine analytically using an Agilent 7890 GC coupled with 
a 5975 MSD (Agilent Technologies; Newark, DE, USA). The chromatographic separation 
was achieved using an Ultra-2 capillary column (25m × 0.32mm × 0.52µM, Agilent 
Technologies; Andover, MA, USA) with research grade helium carrier gas as previously 
described.10 Results are the mean and standard deviations of five replicate analyses.
Tobacco specific nitrosamines
Tobacco filler from individual cigarettes was removed from the paper wrapper and ground 
to uniformity with a Cuisinart® Spice and Nut grinder. For each cigarette type, five 0.25 g 
aliquots of the ground filler were measured into 15 mL amber vials and spiked with 100 µL 
internal standard solution, representing 100 ng 13C labeled standard for each analyte. Ten 
mL of 100 mM aqueous ammonium acetate solution was added to each sample and shaken 
for 60 minutes at 250 rpm on a Benchmark IncuShaker 10 L (Benchmark Scientific, Edison, 
NJ, USA) Approximately 0.5 mL of the extract was pipetted into a Thompson Filter Vial 
and press-filtered at 0.45 µm.
Analytical separation was performed on an Agilent 1200 G1312B binary pump. (Agilent 
Technologies, Santa Clara, CA) using a 5µm particle size Xterra MS C18 4.6 × 50mm 
HPLC column (Waters Corporation, Milford, MA, USA) with mobile phase pumped at 1 
mL/min at 60°C. Elution began with 95% solution A (5mM aqueous ammonium acetate), 
5% solution B (95% acetonitrile, 5% water with 5mM ammonium acetate) mobile phase for 
1 min, followed by a 1 min gradient to 65% solution A, 35% solution B. The mobile phase 
was maintained at 65% solution A, 35% solution B for 3 min, followed by a 2 min gradient 
to the original mobile phase. Analytes were quantitated with an API 4000 triple quadrupole 
mass spectrometer (Sciex Corporation, Farmington MA, USA) working in positive 
electrospray ionization mode as previously described.11 Tandem mass spectrometry data 
was evaluated and quantitated using Sciex Analyst 1.5 software.
Alkaloids
Analyses of alkaloids were performed using an Agilent 7890 GC coupled with a 7000 
Triple-Quad detector (Agilent Technologies, Newark, DE, USA). The chromatographic 
separation was accomplished using a DB-1701 capillary column (30m × 0.250 µM, 0.25 µM, 
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J&W Scientific) with research grade helium used as the carrier gas as previously 
described.12 Results are the mean and standard deviations of five replicate analyses (N = 5).
Polycyclic Aromatic Hydrocarbons
Tobacco filler from individual cigarettes were weighed, spiked with an isotopically 
labeled13C-PAH mixture as an internal standard, extracted with 10 ml cyclohexane 
followed by evaporation to 1 ml. Extracts were filtered through a 0.45 µM Nylon syringe 
filter. The PAHs were subsequently analyzed by SIM GC/MS, normalized to tobacco weight 
and expressed in nanograms of analyte per gram tobacco. Analytes measured included 
acenaphthene (ACE), acenaphthylene (ACL), anthracene (ANT), benzo[a]pyrene (BAP), 
benzo[e]pyrene (BEP), chrysene (CHR), fluoranthene (FLR), fluorene (FLU), naphthalene 
(NAP), phenanthrene (PHE), pyrene (PYR), benz[a]anthracene (BAA), 
benzo[b]fluoranthene (BBF), and benzo[k]fluoranthene (BKF). Lowest reportable levels 
were determined as the concentration of the lowest standards for each analyte. Five 
replicates were analyzed for each variety.
Nicotine
Tobacco filler from individual cigarettes was removed from the paper wrapper, 5 mL of 2N 
NaOH was added to 1.0 grams of tobacco filler in a 60 mL amber vial, followed by 
extraction with 50 mL of an MTBE stock that contained quinoline as an internal standard. A 
1 mL aliquot of the extract was placed in a 2 mL amber vial for GC/MS analysis. The 
sample preparation and nicotine analytical method have been previously described.13 Five 
replicates were analyzed for each variety.
Ammonia
Tobacco filler from individual cigarettes was removed from the paper wrapper, placed into a 
60-mL amber bottle, and weighed. Deionized water (30 mL) was added and the sample was 
sealed with a PTFE-lined cap. The sample was shaken for 30 min at 160 rpm on a Max Q 
2000 shaker (Barnstead/Labline, Dubuque, IA, USA). A 1.5mL sample aliquot was 
centrifuged in a Sorval Pico Biofuge (Thermo Fisher, Waltham, MA, USA) at 13,000 rpm 
for 5 min to remove tobacco debris. A 10:1 water to sample dilution was made in a 1.5 mL 
sample vial. The sample was vortexed and placed in a sample tray for analysis. Five 
replicates were analyzed for each variety.
An ISO Guide 34 1000 mg/L ammonium standard was purchased from Sigma Aldrich (St. 
Louis, MO, USA). Ultrapure water used in all procedures was from an Aqua Solutions water 
system (Aqua Solutions, Jasper, GA, USA).
Samples (25 µL injections) were analyzed with a Dionex ICS-3000 chromatography system 
with Chromeleon version 6.8 software and a 4 mm Ion Pac CS12A cation exchange column 
(Thermo Scientific, Sunnyvale, CA, USA). Isocratic separation of the ammonium ion was 
achieved using a 20 mM methanesulfonic acid eluent prepared by the EG40 eluent generator 
with cation self-regenerating suppressor that required only an ultrapure water source in order 
to suppress the conductance from the eluent (Thermo Scientific, Sunnyvale, CA USA). The 
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column temperature was maintained at 25°C with a run time of 15 minutes. Ammonium ions 
were detected using a conductivity detector.
Inorganic Constituents
Tobacco filler from 4 individual cigarettes of each variety was removed from the paper 
wrapper and combined for analysis. The tobacco was dried for 3 hours at 90°C and rendered 
more homogeneous by grinding for 20 seconds with a Smart Grind coffee grinder (Black 
and Decker, Middleton, WI, USA). Samples (0.100 to 0.150 g) were digested with a 
Milestone Ethos microwave system and analyzed with “Triple Quad” Inductively Coupled 
Plasma Mass Spectrometry as previously described.14 Dried tobacco was analyzed for 
mercury using a combustion mercury analyzer as previously described15 with minor 
modification.16 Quality control was maintained throughout using Reference tobacco 1S3 
(North Carolina State University, Raleigh, NC, USA) and certified reference material 
(CRM) CTA-OTL-1 (Instytucie Chemii i Techniki Jadrowej, Warszawa, Poland) as 
previously described.14,16 Results are reported as the mean and standard deviations of 5 
replicate analyses.
RESULTS
Physical Properties
Based on physical properties, the cigarette paper seemed consistent for all SPECTRUM 
varieties. Cigarette diameter, circumference, tip length (Table 1), and paper porosity differed 
negligibly from variety to variety. The average paper porosity for all SPECTRUM cigarette 
varieties was 31.5 ± 3.7 CORESTA units. All measured physical properties are in Tables 1 
and 2.
Menthol Results
Menthol concentrations varied greatly among the SPECTRUM cigarettes. Twelve 
mentholated products (NRC101, NRC103, NRC105, NRC201, NRC301, NRC302, 
NRC401, NRC405, NRC501, NRC601, NRC602, and NRC701) had menthol concentrations 
ranging from 4970 – 7540 µg menthol/cigarette. Non-mentholated products had measured 
menthol concentrations ranging from 1.1 – 114.0 µg/cigarette. Both of these ranges were 
consistent with menthol concentrations recently reported for commercial menthol and non-
menthol cigarette brands sold in the United States.17 Results are reported in Table 3.
Nitrosamines
Results for NNN (N-nitrosonornicotine) and NNK (4-(N-nitrosomethylamino)-1-(3-
pyridyl)-1-butanone) were reported in Table 3. NNN concentrations ranged from 963 ng/g to 
1732 ng/g, NNK values were 45.2 ng/g to 517 ng/g. As expected, concentrations of NNN in 
the tobacco filler were higher than that of NNK. These results place the NNN levels of 
SPECTRUM cigarettes within the lower third of the concentration range reported for 
commercial cigarette products.18 The majority of SPECTRUM NNK values were lower than 
the lowest NNK level (330 ng/g) published by Stepanov et al.18
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Polycyclic Aromatic Hydrocarbons
Although PAHs are primarily combustion products, difference in tobacco processing, ie, 
curing practices, can result in PAHs being present in tobacco filler. The results for analyses 
of PAHs in the tobacco from SPECTRUM cigarettes are reported in Table 4. Of the 14 
PAHs analyzed, 8 PAH compounds were present at detectable levels ranging from 0.57 – 
349 ng/g. No detectable levels of BAP, ACL, FLU, ANT, BAA, or NAP were found in the 
SPECTRUM cigarettes. The highest PAH concentrations were found for CHR (193 – 349 
ng/g) and PHE (32.7 – 59.7ng/g), which were detected in all of the products analyzed. The 
compounds PYR (8.47 – 16.6 ng/g) and FLR (7.78 – 11.8 ng/g) had lower levels but were 
detectable in all of the varieties tested. Little data on PAH concentrations in cigarette filler 
tobacco has been published since fire-cured tobacco is not commonly used for filler. 
However, phenanthrene and chrysene, concentrations in all Spectrum variety tobacco fillers 
were higher than the respective concentrations determined in 3R4F (used as a quality 
control, 26.3 ng/g and 3.7 ng/g, respectively), whereas fluoranthene, benzo[e]pyrene and 
benzo[a]pyrene concentrations were lower in all Spectrum variety tobacco fillers than in 
3R4F (15.7 ng/g, 2.0 ng/g, and 1.3 ng/g, respectively).
Nicotine and Minor Alkaloids
The results of analyses for nicotine and minor alkaloids (nornicotine, myosmine, anabasine, 
anatabine, and isonicotine are reported in Table 5. Nicotine concentrations ranged from very 
low to within the range reported for commercial products (0.28 – 25.0 mg/g). The majority 
of products had nicotine concentrations that were well below the levels of comparable 
commercial cigarette products,19 which typically range from 8 – 22 mg/g, indicating a 
selective reduction of nicotine. Overall concentrations of other alkaloids were higher than 
those found in commercial products12 and generally increased with measured nicotine 
concentration for each SPECTRUM product type. Alkaloid concentration ranges for the 
SPECTRUM varieties were 472 – 1235 µg/g for nornicotine, 14.8 – 28.7 µg/g for 
myosmine, 5.9 – 242.4 µg/g for anabasine, 29.7 – 2124 µg/g for anatabine and 3.2 – 64.9 
µg/g for isonicotine.
Inorganic Analytes
Ammonia levels in the tobacco filler differed little between the cigarette varieties, ranging 
from 2.2 to 3.7 mg ammonia per gram of conditioned tobacco filler (Table 6). Within-
variety replicate measurements showed little variation with relative standard deviations 
ranging from 1.6 to 5.6 %. This range is in line with previously reported ammonia 
concentrations in tobacco filler.20
The results for 11 inorganic harmful and potentially harmful constituents of SPECTRUM 
cigarette tobacco filler showed that concentration ranges for beryllium, nickel, and arsenic in 
filler tobacco from SPECTRUM cigarettes (Table 6) were lower than the respective ranges 
of concentrations in filler tobacco previously reported for 50 varieties of cigarettes 
commercially available in the United States.15 Chromium, cobalt, and cadmium 
concentrations in SPECTRUM filler tobacco (Table 6) were below, or corresponded with 
the lower range of chromium, cobalt, and cadmium concentrations previously reported.15 
Manganese and lead concentrations in SPECTRUM cigarette filler tobacco fell 
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predominantly within the ranges of manganese and lead concentrations previously 
reported.15
DISCUSSION
Reference materials for analytical or clinical purposes are extremely useful to provide a 
consistent measurement process and to test various hypotheses. For example, when a 
measurement result for a reliable reference material is within the range specified for a 
specific property of the material, valid inferences may be made regarding the accuracy of 
measurements of that property when using the same method for measurements of 
uncharacterized samples with the same matrix. Reference materials may thus be utilized to 
infer that laboratories that can produce acceptable measurement results with a specific 
reference material are intercalibrated with other laboratories that have also been able to 
produce acceptable results.21,22 Since 1968, 17 Monitor quality control cigarettes, 
“reference” cigarettes and smokeless tobacco products have been produced and made 
available to researchers by CORESTA and the University of Kentucky for analytical 
chemistry and toxicology testing.23–25 In addition, 9 smokeless tobacco “reference” 
products are currently distributed by North Carolina State University.26 Manufacturers and 
related groups provide limited characterization of the design and chemistry of the quality 
control and reference products.24–29 These reference and monitor products are an invaluable 
resource to the research community engaged in analytical chemistry method development, 
chemical analysis of tobacco and tobacco smoke, and toxicological tobacco product 
research. However, tobacco reference products are produced from tobacco, an agricultural 
product, and, consequently, they are unlikely to be sufficiently characterized, stable, and 
homogenous in nature to meet the definition of a Standard Reference Material.21 However 
these products have a long history of use as quality control materials and have been analyzed 
and reported in the scientific literature alongside commercial products.27–29
Reference tobacco products are typically accompanied by a disclaimer that they are not for 
human consumption.25,26 Because of this restriction, researchers use commercial tobacco 
products in clinical studies requiring subjects to smoke tobacco cigarettes or use smokeless 
tobacco. Manufacturers can remove commercial tobacco products from the market place 
without notice and are not required to publicly disclose the chemical constituents in their 
products. Also, only a limited number of commercial products have been available to study 
cigarettes that differ substantially in nicotine content.30
Well characterized research cigarettes suitable for human consumption are an important tool 
in clinical studies such as those investigating the physiological impacts of cigarettes 
delivering various levels of nicotine, the combined impact of nicotine replacement and 
reduced nicotine cigarettes on nicotine addiction, and the relationship between nicotine dose 
and smoking behavior. In the work reported here we observe that most constituents, 
including the flavor compound menthol, are at or near the levels typically reported for 
commercial U.S. cigarette brands. Nicotine measurements confirm the targeted reduction of 
nicotine in the tobacco filler. Concentrations of other tobacco alkaloids were not likewise 
reduced. For example, while NNN and NNK were at the lower end of values reported for 
commercial products,18 overall concentrations of minor tobacco alkaloids that are precursors 
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for formation of TSNAs in a burning cigarette,12,28 were higher than those found in 
commercial products. It has also been suggested that the minor tobacco alkaloids interact 
with the reinforcing properties of nicotine and thus may influence smoking behavior.32
The overall similarity in the chemistry and physical properties of SPECTRUM cigarettes to 
commercial cigarettes has potential implications for the acceptability and use behavior of 
study participants using the products. Baseline information on harmful and potentially 
harmful constituents in reference tobacco products, particularly constituent levels that fall 
outside typical ranges reported for commercial products, provide researchers with the 
opportunity to monitor smoking behavior and to identify biomarkers that will inform efforts 
to understand the role of nicotine in creating and sustaining addiction.
IMPLICATIONS FOR TOBACCO REGULATION
The large amount of analytical data on Harmful and Potentially Harmful Constituents 
(HPHCs) in the filler tobacco in SPECTRUM cigarettes presented here will supplement data 
on concentrations of already reported directly to the FDA center for Tobacco Products and 
in published manuscripts.14–17,28 In addition, the concentrations of nicotine and related 
alkaloids reported here will better enable researchers to interpret data in smoking 
topography and addiction studies. These data together with topography and addiction studies 
will better inform regulatory agencies when making decisions on regulatory levels for 
HPHCs and on the impact of reduced nicotine levels on potential for product addictiveness 
and cessation success.
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